ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000270949.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.035021749	Resistant
ENSG00000270949.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.044310146	Sensitive